Invented by Dr Mike Owen from Independent Pharmaceutical And Biotech Consultant
- References (2)
- Inventor Info
|Antigen/Gene or Protein Targets
|In vivo study of p23 knockout, golgi apparatus and early secretory pathway function
|A p23 targeting vector, constructed from genomic fragments, but replacing exon 1 of the p23 gene with a resistance marker, was transfected into 129 ES cells. Properly targeted ES cells containing a homologous recombination event were selected, and injected into C57BL/6 blastocysts. Chimeric offspring were mated to C57BL/6 mice to generate mice heterozygous for the p23 knockout allele, p23+/- mice.
|Golgi apparatus abnormalities
|Cancer, Cell Signaling & Signal Transduction, Epigenetics & Nuclear Signalling, Genetic Studies Tools, Immunology
Genetic Bkg: 129/C57BL/6.
There are 2 reference entries for this reagent.View All References